New AI-powered feature helps regulated manufacturers streamline electronic batch record creation MasterControl, a leading provider of quality, manufacturing, and asset management software solutions, today announced the beta release of Master Template Generator at its Masters Conference in Berlin. This new AI-powered capability helps manufacturers using MasterControl's Manufacturing Excellence (Mx) Production Records module to optimize their […]

Florida Southern College is proud to welcome its first cohort of students to the School of Architecture on the historic Frank Lloyd Wright campus in Lakeland, Florida. Set to open fall 2025, this groundbreaking initiative marks a significant milestone in the College's commitment to architectural education and preservation and offers unparalleled opportunities for students to

(NYSE:KAI), WESTFORD, Mass., May 15, 2025 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.34 per share to be paid on August 7, 2025 to stockholders of record as of the close of business on July 10, 2025. Future declarations

(NASDAQ:VVOS), Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and distribution model Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May 15, 2025 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc.

(NasdaqGM:SCYX), Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for ibrexafungerp in the treatment of acute VVC. SCYNEXIS will receive a milestone payment from Hansoh upon commercialization

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update GlobeNewswire May 15, 2025 Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and distribution model Management to Host Conference Call today

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire May 15, 2025 Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for ibrexafungerp in the

Kadant Declares Cash Dividend GlobeNewswire May 15, 2025 WESTFORD, Mass., May 15, 2025 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.34 per share to be paid on August 7, 2025 to stockholders of record as of the close of

(NASDAQ:SSBK),(NASDAQ:KRON),(NASDAQ:RGLS),(NASDAQ:XAGE), BALA CYNWYD, Pa., May 15, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Regulus Therapeutics Inc. (Nasdaq – RGLS) Under

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq – KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (Nasdaq – XAGE), Southern States Bancshares, Inc. (Nasdaq – SSBK) GlobeNewswire May 15, 2025 BALA CYNWYD, Pa., May 15, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors